Cardiovascular disease
TítuloThe modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease
... Citation: Borràs Sans M, Pe´rez-Fonta´n M, Martinez-Alonso M, Bajo A, Betriu À, Valdivielso JM, et al. (2018) Correction: The modality of dialysis does not influence atheromatous vascular disease progression or ...
6
Nutritional Genomics as cardiovascular disease control in the near future
... ing cardiovascular disease, without neglecting the effects of a diet rich in saturated fatty ...of cardiovascular diseases. In conclusion, the treatment of cardiovascular disease ...
7
The action of ovarian hormones in cardiovascular disease
... of cardiovascular diseases such as venous thrombosis, myocardial infarction (MI) and stroke have been ...of cardiovascular risk factors but increase the incidence of MI in their ...
17
Cocoa polyphenols and inflammatory markers of cardiovascular disease.
... 2008, cardiovascular disease (CVD) accounted for 30% ...The cardiovascular epidemic is rapidly advancing in the ...from cardiovascular disorders ...in cardiovascular events, such as ...
37
Glycated hemoglobin, diabetes mellitus and cardiovascular disease risk
... for cardiovascular events such as myocardial infarction, stroke, coronary heart disease and heart ...with cardiovascular outcomes and cause of death, and to analyse the range of HbA1c levels that is ...
322
Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease
... In this study we demonstrate an increased preva- lence of risk factors for CVD in patients undergoing cholecystectomy. Although there was a trend towards association with differences in age, sex, and BMI, the increased ...
5
Update of the cardiovascular disease policy model to predict cardiovascular events in Argentina
... enfermedad cardiovascular en Argentina. La en- fermedad cardiovascular (ECV) es la principal causa de muerte en ...El Cardiovascular Disease Policy Model (CVDPM, por sus siglas en inglés) es ...
7
TítuloThe modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease
... Cardiovascular disease (CVD) is the leading cause of mortality in patients with end stage renal disease (ESRD) [1,2]. Available evidence suggests that atherosclerosis is a primary contributor to this ...
16
CD-Depression and Cardiovascular Disease
... and cardiovascular disease, and studies should be designed to answer whether treatment of depression can improve cardiovascular mortality and morbid- ...with cardiovascular disease is a ...
5
Nutritional management of cardiovascular disease in the near future
... the cardiovascular disease is multifactorial relationship processes including genetic factors and potentially modifiable risk factors, such as ...developing cardiovascular disease, without ...
7
ECG time series data mining for cardiovascular disease risk assessment
... Indeed, cardiovascular diseases are the first cause of mortality in Spain with more than 123,000 cases and investments estimated in €2 billon annually, representing ...
99
Mediterranean alcohol-drinking pattern and the incidence of cardiovascular Disease and cardiovascular mortality: the SUN Project
... of cardiovascular event or date of the last follow-up questionnaire, whichever came first, and age was used as the underlying time ...(h/day), cardiovascular treatment at baseline, and prevalent ...
11
Hormone replacement therapy and cardiovascular disease in the hypogonadal adult men
... perjuicio cardiovascular, pero estos tienen deficiencias en cuanto a la selección de los pacientes, el análisis realizado en cada estudio, gran heterogeneidad en los estudios incluidos en los metaanálisis, y por ...
9
Melatonin and human cardiovascular disease
... The possible therapeutic role of melatonin in the pathophysiology of coronary artery disorder (CAD) is increasingly being recognized. In humans, exogenous melatonin has been shown to decrease nocturnal hypertension, ...
28
Association between ideal cardiovascular health and markers of subclinical cardiovascular disease
... health factors and behaviors (ie, prehypertension, impaired glucose tolerance, borderline hypercholesterolemia, or medically controlled levels of these risk factors) still experienced a lower burden of sub- clinical ...
8
Defense mechanisms in cardiovascular disease patients with and without panic disorder
... in cardiovascular diseases, type A personality, anger, hostility, anxiety, and depression have been proved to participate in this kind of ...cardiac disease might lack adaptive coping defense mechanisms to ...
9
Burden of disease in Nariño, Colombia, 2010
... of disease in women in the age group 45-59 years, non-communicable diseases prevail like cervical malignancy, malignant stomach tumor, malignant breast tumor, ischemic cardiovascular disease, cardio- ...
8
Metabolic syndrome-1.pdf
... Consensus process The consensus statement emerged following detailed discussions at the IDF workshop. After the workshop, a writing group produced a consensus statement which was reviewed and approved by all ...
12
Analysis of the evolving clinical phenotype and molecular mechanisms in Williams-Beuren syndrome
... We also studied 7 SNPs that have been previously associated with hypertension in GWAS or other smaller association studies. Although none of the comparisons remained significant after Bonferroni´s correction, we found ...
239
Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link?
... with cardiovascular disease, most of them with asymptomatic PAD and identified by an ABI < ...with cardiovascular disease, to- gether with the duration of the disease and smoking ...
10
